- Home
- AQMS vs CDIO Comparison
AQMS vs CDIO Comparison
Compare AQMS & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQMS
- CDIO
- Stock Information
- Founded
- AQMS 2014
- CDIO 2017
- Country
- AQMS United States
- CDIO United States
- Employees
- AQMS N/A
- CDIO N/A
- Industry
- AQMS Metal Fabrications
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- AQMS Industrials
- CDIO Health Care
- Exchange
- AQMS Nasdaq
- CDIO Nasdaq
- Market Cap
- AQMS 5.5M
- CDIO 6.4M
- IPO Year
- AQMS 2015
- CDIO N/A
- Fundamental
- Price
- AQMS $0.53
- CDIO $4.35
- Analyst Decision
- AQMS Strong Buy
- CDIO Buy
- Analyst Count
- AQMS 3
- CDIO 1
- Target Price
- AQMS $21.00
- CDIO $60.00
- AVG Volume (30 Days)
- AQMS 6.3M
- CDIO 39.0K
- Earning Date
- AQMS 08-04-2025
- CDIO 08-11-2025
- Dividend Yield
- AQMS N/A
- CDIO N/A
- EPS Growth
- AQMS N/A
- CDIO N/A
- EPS
- AQMS N/A
- CDIO N/A
- Revenue
- AQMS N/A
- CDIO $19,902.00
- Revenue This Year
- AQMS N/A
- CDIO $1,434.82
- Revenue Next Year
- AQMS $550.00
- CDIO $4,661.91
- P/E Ratio
- AQMS N/A
- CDIO N/A
- Revenue Growth
- AQMS N/A
- CDIO N/A
- 52 Week Low
- AQMS $0.47
- CDIO $3.22
- 52 Week High
- AQMS $7.80
- CDIO $53.10
- Technical
- Relative Strength Index (RSI)
- AQMS 36.08
- CDIO 50.03
- Support Level
- AQMS $0.47
- CDIO $3.43
- Resistance Level
- AQMS $1.02
- CDIO $4.18
- Average True Range (ATR)
- AQMS 0.09
- CDIO 0.27
- MACD
- AQMS 0.01
- CDIO 0.21
- Stochastic Oscillator
- AQMS 6.58
- CDIO 96.41
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.